StonvexLoading…
StonvexStonvexStonvexCore line items from AVGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-02 | Annual 2024 2024-11-03 | Annual 2023 2023-10-29 | Annual 2022 2022-10-30 |
|---|---|---|---|---|
Revenue | $63.89B | $51.57B | $35.82B | $33.20B |
Operating Income | $25.48B | $13.46B | $16.21B | $14.22B |
Net Income | $23.13B | $5.89B | $14.08B | $11.49B |
EPS (Diluted) | $4.77 | $1.23 | $3.30 | $2.65 |
Total Assets | $171.09B | $165.65B | $72.86B | $73.25B |
Total Liabilities | $89.80B | $97.97B | $48.87B | $50.54B |
Cash & Equivalents | $16.18B | $9.35B | $14.19B | $12.42B |
Free Cash Flow OCF − CapEx | $26.91B | $19.41B | $17.63B | $16.31B |
Shares Outstanding | 4.74B | 4.69B | 4.14B | 418.00M |